{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T02:39:28Z","timestamp":1764470368382,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0673-4","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T09:16:39Z","timestamp":1505121399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention"],"prefix":"10.1186","volume":"17","author":[{"given":"Mao-Jen","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-4183","authenticated-orcid":false,"given":"Han-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"673_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.0000109693.64957.20","volume":"109","author":"V Mathew","year":"2004","unstructured":"Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with Tranilast and its outcomes (PRESTO) trial. Circulation. 2004;109:476\u201380.","journal-title":"Circulation"},{"key":"673_CR2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9149(02)02770-4","volume":"90","author":"WK Laskey","year":"2002","unstructured":"Laskey WK, Seizer F, Viachos HA, Johnston J, Jacobs A, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the national, heart, lung, and blood institute dynamic registry). Am J Cardiol. 2002;90:1062\u20137.","journal-title":"Am J Cardiol"},{"key":"673_CR3","first-page":"1786","volume":"44","author":"PJ Best","year":"2004","unstructured":"Best PJ, Berger PB, Davis BR, Grines CL, Sadeghi HM, PRESTO Investigators. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol. 2004;44:1786\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"673_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4244\/EIJV5I8A152","volume":"5","author":"A Norhammar","year":"2010","unstructured":"Norhammar A, Lagerqvist B, Saleh N. Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry. EuroIntervention. 2010;5:891\u20137.","journal-title":"EuroIntervention"},{"key":"673_CR5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00392-011-0347-7","volume":"100","author":"E Kaya","year":"2011","unstructured":"Kaya E, Cuneo A, Hochadel M, J\u00fcnger C, Stepper W, et al. Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents. Clin Res Cardiol. 2011;100:1103\u20139.","journal-title":"Clin Res Cardiol"},{"key":"673_CR6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ahj.2004.10.010","volume":"149","author":"JH Ix","year":"2005","unstructured":"Ix JH, Mercado N, Schlipak MG, Lemos PA, Boersma E, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the arterial revascularization therapies study (ARTS). Am Heart J. 2005;149:512\u20139.","journal-title":"Am Heart J"},{"key":"673_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ccd.10103","volume":"55","author":"L Gruberg","year":"2002","unstructured":"Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002;55:66\u201372.","journal-title":"Catheter Cardiovasc Interv"},{"key":"673_CR8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2011.06.012","volume":"4","author":"AJ Saltzman","year":"2011","unstructured":"Saltzman AJ, Stone GW, Claessen BE, Narula A, Leon-Reyes S, et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. JACC Cardiovasc Interv. 2011;4:1011\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"673_CR9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcin.2011.05.022","volume":"4","author":"EB Hanna","year":"2011","unstructured":"Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, et al. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:1002\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"673_CR10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijcard.2014.10.116","volume":"179","author":"R Klempfner","year":"2015","unstructured":"Klempfner R, Elis A, Matezky S, Keren G, Roth A, et al. Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: insights from the ACS Israeli survey (ACSIS) 2000-2010. Int J Cardiol. 2015;179:546\u201351.","journal-title":"Int J Cardiol"},{"key":"673_CR11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amjcard.2011.10.018","volume":"109","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, et al. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109:629\u201335.","journal-title":"Am J Cardiol"},{"key":"673_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164111427752","volume":"9","author":"MB Kahn","year":"2012","unstructured":"Kahn MB, Cubbon RM, Mercer B, Wheatcroft AC, Gherardi G, et al. Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era. Diab Vasc Dis Res. 2012;9:3\u20139.","journal-title":"Diab Vasc Dis Res"},{"key":"673_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2169\/internalmedicine.47.0932","volume":"47","author":"K Goto","year":"2008","unstructured":"Goto K, Shiode N, Shirota K, Fukuda Y, Kitamura F, et al. Impact of impaired renal function and diabetes on long-term prognosis in patients undergoing primary angioplasty for acute coronary syndrome. Intern Med. 2008;47:907\u201313.","journal-title":"Intern Med"},{"issue":"suppl 1","key":"673_CR14","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(suppl 1):S67\u201374.","journal-title":"Diabetes Care"},{"key":"673_CR15","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Disney Dis. 2003;42:S1\u2013S201.","journal-title":"Am J Kid Disney Dis"},{"key":"673_CR16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961\u201372.","journal-title":"N Engl J Med"},{"key":"673_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2369-14-152","volume":"14","author":"S Iimori","year":"2013","unstructured":"Iimori S, Noda Y, Okado T, Naito S, Toda T, et al. Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol. 2013;14:152.","journal-title":"BMC Nephrol"},{"key":"673_CR18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.606962","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, CAFE Investigators. Anglo-Scandinavian Cardia outcomes trial investigators; CAFE steering committee and writing committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113:1213\u201325.","journal-title":"Circulation"},{"key":"673_CR19","doi-asserted-by":"crossref","first-page":"e3218","DOI":"10.1097\/MD.0000000000003218","volume":"95","author":"MJ Lin","year":"2016","unstructured":"Lin MJ, Chen CY, Lin HD, Lin CS, Wu HP. Prognostic significance of central pulse pressure for mortality in patients with coronary artery disease receiving repeated percutaneous coronary intervention. Medicine (Baltimore). 2016;95:e3218.","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"673_CR20","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, MCCagg A, White JA, IMPROVE-IT Investigators. Ezetimibe added to Statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"key":"673_CR21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12872-016-0454-5","volume":"17","author":"MJ Lin","year":"2017","unstructured":"Lin MJ, Chen CY, Lin HD, Wu HP. Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention. BMC Cardiovasc Disord. 2017;17:12.","journal-title":"BMC Cardiovasc Disord"},{"key":"673_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11883-014-0422-4","volume":"16","author":"M Valgimigli","year":"2014","unstructured":"Valgimigli M, Biscaglia S. Stable angina pectoris. Current atherosclero Rep. 2014;16:422.","journal-title":"Current atherosclero Rep"},{"key":"673_CR23","first-page":"853","volume":"3","author":"HA Hadi","year":"2007","unstructured":"Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853\u201376.","journal-title":"Vasc Health Risk Manag"},{"key":"673_CR24","first-page":"1","volume":"0","author":"DT Chan","year":"2015","unstructured":"Chan DT, Watts GF, Irish AB, Dogra GK. Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions. Nephrol Dial Transplant. 2015;0:1\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"673_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ccd.26364","volume":"88","author":"M Tebaldi","year":"2016","unstructured":"Tebaldi M, Biscaqlia S, Fineschi M, Manari A, Menozzi M, et al. Fractional flow reserve evaluation and chronic kidney disease: analysis from a multicenter Italian registry (the FREAK study). Catheter Cardiovasc Interv. 2016;88(4):555\u201362.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T09:16:44Z","timestamp":1505121404000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0673-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0673-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"article-number":"242"}}